These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11094075)

  • 1. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).
    Trapasso F; Iuliano R; Boccia A; Stella A; Visconti R; Bruni P; Baldassarre G; Santoro M; Viglietto G; Fusco A
    Mol Cell Biol; 2000 Dec; 20(24):9236-46. PubMed ID: 11094075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
    Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A
    Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
    Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.
    Pera IL; Iuliano R; Florio T; Susini C; Trapasso F; Santoro M; Chiariotti L; Schettini G; Viglietto G; Fusco A
    Oncogene; 2005 Apr; 24(19):3187-95. PubMed ID: 15735685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo.
    Trapasso F; Yendamuri S; Dumon KR; Iuliano R; Cesari R; Feig B; Seto R; Infante L; Ishii H; Vecchione A; During MJ; Croce CM; Fusco A
    Carcinogenesis; 2004 Nov; 25(11):2107-14. PubMed ID: 15231692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
    Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
    J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27(Kip1): role in angiotensin II-mediated hypertrophy of proximal tubular cells.
    Hannken T; Schroeder R; Zahner G; Stahl RAK; Wolf G
    J Am Soc Nephrol; 2000 Aug; 11(8):1387-1397. PubMed ID: 10906152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.
    Motti ML; Califano D; Troncone G; De Marco C; Migliaccio I; Palmieri E; Pezzullo L; Palombini L; Fusco A; Viglietto G
    Am J Pathol; 2005 Mar; 166(3):737-49. PubMed ID: 15743786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1.
    Pagès P; Benali N; Saint-Laurent N; Estève JP; Schally AV; Tkaczuk J; Vaysse N; Susini C; Buscail L
    J Biol Chem; 1999 May; 274(21):15186-93. PubMed ID: 10329727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells.
    Rivard N; Boucher MJ; Asselin C; L'Allemain G
    Am J Physiol; 1999 Oct; 277(4):C652-64. PubMed ID: 10516095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.
    Takeuchi S; Okumura T; Motomura W; Nagamine M; Takahashi N; Kohgo Y
    Jpn J Cancer Res; 2002 Jul; 93(7):774-82. PubMed ID: 12149143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27.
    Weber JD; Hu W; Jefcoat SC; Raben DM; Baldassare JJ
    J Biol Chem; 1997 Dec; 272(52):32966-71. PubMed ID: 9407076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p27kip1 Antisense-induced proliferative activity of rat corneal endothelial cells.
    Kikuchi M; Harris DL; Obara Y; Senoo T; Joyce NC
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1763-70. PubMed ID: 15161838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
    Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells.
    Delmas C; Manenti S; Boudjelal A; Peyssonnaux C; Eychène A; Darbon JM
    J Biol Chem; 2001 Sep; 276(37):34958-65. PubMed ID: 11418594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
    Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.
    Martelli ML; Trapasso F; Bruni P; Berlingieri MT; Battaglia C; Vento MT; Belletti B; Iuliano R; Santoro M; Viglietto G; Fusco A
    Exp Cell Res; 1998 Nov; 245(1):195-202. PubMed ID: 9828116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase Cdelta inhibition of S-phase transition in capillary endothelial cells involves the cyclin-dependent kinase inhibitor p27(Kip1).
    Ashton AW; Watanabe G; Albanese C; Harrington EO; Ware JA; Pestell RG
    J Biol Chem; 1999 Jul; 274(30):20805-11. PubMed ID: 10409620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.